Clinical review report. Ozenoxacin 1% cream (Ozanex) (Ferrer internacional, S.A.) : indication : the topical treatment of impetigo in patients aged two months and older.

Clinical review report. indication : the topical treatment of impetigo in patients aged two months and older. Ozenoxacin 1% cream (Ozanex) (Ferrer internacional, S.A.) :

Show other versions (2)

The objective of this report is to perform a systematic review of the beneficial and harmful effects of ozenoxacin 1% cream for the topical treatment of impetigo in patients aged two months and older.

Saved in:
Bibliographic Details
Online Access: Full text
Format: Electronic eBook
Language:English
Published: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2018
Series:Common drug review clinical review report.
Subjects:
Impetigo > drug therapy.
Infant.
Child.
Aminopyridines > therapeutic use.
Quinolones > therapeutic use.
Treatment Outcome.
Children.
Family members.
Canada.
Systematic Review.
Tables.

Internet

Full text

Similar Items